Cynata Therapeutics is public listed, with a valuation of -.
Alternatives.pe lists Cynata Therapeutics's financials, valuation trends, ownership structure and transaction activity.
Last Updated: 2026-07-21
Browse all uploaded documents here
Audited Financial Statement 2024
Audited Financial Statement
ViewAudited Financial Statement 2023
Audited Financial Statement
ViewExplore the latest updates and insights
$1m MRFF Grant Awarded to Fund Investigation of Cynata's MSCs as a Treatment for Heart Disease
Fidelity International just invested $5.2 million in Australian stem cell company Cynata ... see summary
A view of the number of employees over time
Audited Financial Statement 2022
Audited Financial Statement
ViewAudited Financial Statement 2021
Audited Financial Statement
ViewCynata Therapeutics raises AUD 5.2 million from Fidelity International.
Cynata Therapeutics secures funds to progress stem cell technology
Cynata Therapeutics raises $2.9M
Key members of the management team